What is Sana Biotechnology's net investment in lease?

Sana Biotechnology (SANA) reported net investment in lease of $35.85M in Q1 2026.

How has Sana Biotechnology's net investment in lease changed year-over-year?

Sana Biotechnology's net investment in lease decreased by 34.6% year-over-year, from $54.84M to $35.85M.

What is the long-term trend for Sana Biotechnology's net investment in lease?

Over 5 years (2020 to 2025), Sana Biotechnology's net investment in lease has grown at a -9.5% compound annual growth rate (CAGR), from $63.17M to $38.31M.

Sana Biotechnology SANA Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

CRISPR TherapeuticsCRSP

——

Cullinan Therapeutics, Inc.CGEM

——

Intellia TherapeuticsNTLA

——

Iovance Biotherapeutics, Inc.IOVA

——

PrecigenPGEN

——

Other financials

Income statement

See full

Operating income-$48.6M+4.0%

Net income-$47.2M+4.4%

EPS (diluted)-$0.17+19.0%

Balance sheet

See full

Cash & equivalents$83.8M-12.8%

Total debt$75.3M-17.5%

Total equity$119.2M-43.0%

Total assets$373.6M-16.1%

Cash flow

See full

Operating cash flow-$37.4M+23.2%

CapEx$288.0K+112%

Free cash flow-$37.7M+22.8%

Valuation

See full

Market cap$907.23M+54.1%

Enterprise value$898.76M+53.9%

Returns & leverage

See full

Return on equity-147.4%-2,468pp

Debt / equity0.6×+0.2×

Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sana Biotechnology's net investment in lease?: Sana Biotechnology (SANA) reported net investment in lease of $35.85M in Q1 2026.
How has Sana Biotechnology's net investment in lease changed year-over-year?: Sana Biotechnology's net investment in lease decreased by 34.6% year-over-year, from $54.84M to $35.85M.
What is the long-term trend for Sana Biotechnology's net investment in lease?: Over 5 years (2020 to 2025), Sana Biotechnology's net investment in lease has grown at a -9.5% compound annual growth rate (CAGR), from $63.17M to $38.31M.